drugs for functional gastrointestinal disorders	treat	irritable bowel syndrome
drugs for functional gastrointestinal disorders	treat	functional dyspepsia
drugs for functional gastrointestinal disorders	include	antispasmodics
drugs for functional gastrointestinal disorders	include	laxatives
drugs for functional gastrointestinal disorders	include	antidiarrheals
drugs for functional gastrointestinal disorders	include	prokinetics
drugs for functional gastrointestinal disorders	include	antidepressants
antispasmodics	relieve	abdominal pain
laxatives	relieve	constipation
antidiarrheals	relieve	diarrhea
prokinetics	improve	gastric motility
antidepressants	modulate	gut-brain axis
irritable bowel syndrome	has symptom	bloating
functional dyspepsia	has symptom	early satiety
abdominal pain	caused by	visceral hypersensitivity
constipation	caused by	slow transit
diarrhea	caused by	increased motility
gut-brain axis	involves	serotonin
serotonin	regulates	gut function
drugs for functional gastrointestinal disorders	may cause	dry mouth
drugs for functional gastrointestinal disorders	may cause	dizziness
drugs for functional gastrointestinal disorders	may cause	constipation
drugs for functional gastrointestinal disorders	may cause	diarrhea
drugs for functional gastrointestinal disorders	interact with	CYP3A4 substrates
CYP3A4 substrates	include	statins
statins	used for	hyperlipidemia
hyperlipidemia	risk factor	cardiovascular disease
drugs for functional gastrointestinal disorders	contraindicated in	glaucoma
glaucoma	involves	increased intraocular pressure
drugs for functional gastrointestinal disorders	require	dose adjustment
dose adjustment	needed in	renal impairment
renal impairment	affects	drug clearance
drug clearance	occurs in	liver
liver	metabolizes	drugs
drugs for functional gastrointestinal disorders	have	half-life
half-life	determines	dosing frequency
dosing frequency	affects	adherence
adherence	impacts	treatment efficacy
treatment efficacy	measured by	symptom relief
symptom relief	improves	quality of life
quality of life	assessed by	questionnaires
questionnaires	include	IBS-SSS
IBS-SSS	evaluates	irritable bowel syndrome severity
irritable bowel syndrome	classified into	subtypes
subtypes	include	IBS-C
subtypes	include	IBS-D
subtypes	include	IBS-M
IBS-C	characterized by	constipation
IBS-D	characterized by	diarrhea
IBS-M	characterized by	mixed bowel habits
drugs for functional gastrointestinal disorders	target	5-HT3 receptors
5-HT3 receptors	mediate	nausea
nausea	common in	functional dyspepsia
drugs for functional gastrointestinal disorders	target	5-HT4 receptors
5-HT4 receptors	enhance	peristalsis
peristalsis	moves	food
food	digested in	small intestine
small intestine	absorbs	nutrients
nutrients	provide	energy
energy	required for	metabolism
metabolism	involves	enzymes
enzymes	catalyze	reactions
reactions	produce	metabolites
metabolites	excreted by	kidneys
kidneys	filter	blood
blood	contains	plasma
plasma	carries	proteins
proteins	bind	drugs
drug binding	affects	bioavailability
bioavailability	determines	drug concentration
drug concentration	influences	effect
effect	monitored by	physicians
physicians	prescribe	drugs for functional gastrointestinal disorders
prescriptions	filled at	pharmacies
pharmacies	dispense	medications
medications	have	side effects
side effects	reported by	patients
patients	experience	symptoms
symptoms	prompt	doctor visits
doctor visits	lead to	diagnoses
diagnoses	guide	treatments
treatments	aim for	remission
remission	defined as	symptom absence
symptom absence	indicates	recovery
recovery	depends on	adherence
adherence	influenced by	education
education	provided by	healthcare providers
healthcare providers	include	nurses
nurses	administer	care
care	improves	outcomes
outcomes	measured by	metrics
metrics	include	readmission rates
readmission rates	reflect	quality of care
quality of care	enhanced by	guidelines
guidelines	based on	evidence
evidence	derived from	studies
studies	conducted by	researchers
researchers	publish	papers
papers	contribute to	knowledge
knowledge	advances	medicine
